1. Inflammation/Immunology

Inflammation/Immunology

The diseases caused by disorders of the immune system fall into two broad categories: immunodeficiency and autoimmunity. Immunotherapy is also often used in the immunosuppressed (such as HIV patients) and people suffering from other immune deficiencies or autoimmune diseases. This includes regulating factors such as IL-2, IL-10, IFN-α. Infection with HIV is characterized not only by development of profound immunodeficiency but also by sustained inflammation and immune activation. Chronic inflammation as a critical driver of immune dysfunction, premature appearance of aging-related diseases, and immune deficiency.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-NP0235
    Rat haptoglobin 98%
    Rat haptoglobin is a hemoglobin-binding acute-phase protein which possesses anti-inflammatory and antioxidative properties. Rat haptoglobin binds to free hemoglobin and thereby prevent iron-driven oxidative tissue damage.
    Rat haptoglobin
  • HY-NP0236
    Cynomolgus Monkey haptoglobin 98%
    Cynomolgus Monkey haptoglobin is a hemoglobin-binding protein derived from cynomolgus monkeys. Cynomolgus Monkey haptoglobin is generally assumed to be analogous to human serum haptoglobin (Hp).
    Cynomolgus Monkey haptoglobin
  • HY-NP0237
    Cynomolgus Monkey transferrin 98%
    Cynomolgus Monkey transferrin is a cynomolgus monkey-derived protein. Transferrin is the transport of iron in the bloodstream. Transferrin can also act as a growth factor.
    Cynomolgus Monkey transferrin
  • HY-NP0240
    Bovine CB8 of type II collagen
    Bovine CB8 of type II collagen (Bovine cyanogen bromide digested peptide 8) is a cyanobromide digested peptide (CB-peptide) fragment of type II collagen, which can be used to study B cell and T cell epitopes of type II collagen. This product is pepsin-free, making it ideal for studying T cell epitope specificity through proliferation assays. Bovine CB8 of type II collagen can also be used as an antigen for analyzing antibody epitope specificity via ELISA.
    Bovine CB8 of type II collagen
  • HY-NP0241
    Chick CB8 of type II collagen
    Chick CB8 of type II collagen (Chick cyanogen bromide digested peptide 8) is a cyanobromide digested peptide (CB-peptide) fragment of type II collagen, which can be used to study B cell and T cell epitopes of type II collagen. This product is pepsin-free, making it ideal for studying T cell epitope specificity through proliferation assays. Chick CB8 of type II collagen can also be used as an antigen for analyzing antibody epitope specificity via ELISA.
    Chick CB8 of type II collagen
  • HY-NP0242
    Human CB8 of type II collagen
    Human CB8 of type II collagen (Human cyanogen bromide digested peptide 8) is a cyanobromide digested peptide (CB-peptide) fragment of type II collagen, which can be used to study B cell and T cell epitopes of type II collagen. This product is pepsin-free, making it ideal for studying T cell epitope specificity through proliferation assays. Human CB8 of type II collagen can also be used as an antigen for analyzing antibody epitope specificity via ELISA.
    Human CB8 of type II collagen
  • HY-NP0243
    Mouse CB8 of type II collagen
    Mouse CB8 of type II collagen (Mouse cyanogen bromide digested peptide 8) is a cyanobromide digested peptide (CB-peptide) fragment of type II collagen, which can be used to study B cell and T cell epitopes of type II collagen. This product is pepsin-free, making it ideal for studying T cell epitope specificity through proliferation assays. Mouse CB8 of type II collagen can also be used as an antigen for analyzing antibody epitope specificity via ELISA.
    Mouse CB8 of type II collagen
  • HY-NP0244
    Crude Peanut extract
    Crude Peanut extract is a crude peanut extract that can be used to study the pathogenesis of peanut allergy.
    Crude Peanut extract
  • HY-NP0245
    Retinoic acid-HSA 98%
    Retinoic acid-HSA is a conjugate of Retinoic acid (HY-14649) and Human serum albumin (HSA). By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    Retinoic acid-HSA
  • HY-NP0246
    Sulfamerazine-OVA 98%
    Sulfamerazine-OVA is a conjugate of Sulfamerazine (HY-B0512) and Ovalbumin (OVA). By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    Sulfamerazine-OVA
  • HY-NP0247
    Sulfadimidine-BSA 98%
    Sulfadimidine-BSA is a conjugate of Sulfadimidine (HY-B0035) and BSA. By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    Sulfadimidine-BSA
  • HY-NP0248
    Ciprofloxacin-BSA 98%
    Ciprofloxacin-BSA is a conjugate of Ciprofloxacin (HY-B0356) and BSA. By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    Ciprofloxacin-BSA
  • HY-NP0249
    Neomycin-OVA 98%
    Neomycin-OVA is a conjugate of Neomycin (HY-150520) and Ovalbumin (OVA). By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    Neomycin-OVA
  • HY-NP0250
    Kanamycin-BSA 98%
    Kanamycin-BSA is a conjugate of Kanamycin (HY-16566) and BSA. By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    Kanamycin-BSA
  • HY-NP0251
    Ofloxacin-BSA 98%
    Ofloxacin-BSA is a conjugate of Ofloxacin (HY-B0125) and BS. By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    Ofloxacin-BSA
  • HY-NP0252
    Sulfamonomethoxine-BSA 98%
    Sulfamonomethoxine-BSA is a conjugate of Sulfamonomethoxine (HY-B0946) and BSA. By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    Sulfamonomethoxine-BSA
  • HY-NP0253
    Salbutamol-OVA 98%
    Salbutamol-OVA is a conjugate of Salbutamol (HY-B1037) and Ovalbumin (OVA). By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    Salbutamol-OVA
  • HY-NP0254
    Thyroxin-OVA 98%
    Thyroxin-OVA is a conjugate of Thyroxin (HY-101406) and Ovalbumin (OVA). By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    Thyroxin-OVA
  • HY-NP0255
    Amoxicillin-BSA 98%
    Amoxicillin-BSA is a conjugate of Amoxicillin (HY-B0467A) and BSA. By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    Amoxicillin-BSA
  • HY-NP077A
    Phaseolus vulgaris Lectin-P 98%
    Phaseolus vulgaris Lectin-P is the protein form of Phytohemagglutinin before the separation and purification of Phytohemagglutinin-L (PHA-L) and PHA-E. Phaseolus vulgaris Lectin-P can be used to stimulate the proliferation of peripheral mononuclear cells, promote the production of certain cytokines and the expression of membrane surface proteins.
    Phaseolus vulgaris Lectin-P
Cat. No. Product Name / Synonyms Application Reactivity